Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During the forecast period 2023 to 2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney d...
In 2023, the global respiratory distress syndrome management market is expected to be worth US$ 115.4 billion. According to Future Market Insights, the market is expected to grow at a 4.41% CAGR until 2033, valued at US$ 177.7 billion, according to Future Market Insights. Furthermore, according to a recent FMI study...
According to a recent Future Market Insights analysis, the global hyperammonemia treatment market is anticipated to reach a valuation of US$ 1,318.05 Million in 2023 and US$ 2,100 Million by 2033, with a CAGR of 4.77%.The increased frequency of urea cycle diseases, as well as extensive research and development, are...
A recently published study by FMI expects the global alcohol use disorder treatment market demand to augment at a 6.4% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1300 million is expected for the market. The growing number of drug awareness campaigns, preventative programs, a...
Some of the key players in the Vascular Dementia Treatment Market are- Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix Corp., Eisai Co.,...